Cardiology Analysis

Novartis remibrutinib wins Phase 3 in CSU: what it means

chronic spontaneous urticaria · 9 min

SURPASS-CVOT Trial Results: Implications for Mounjaro's Cardiovascular Safety and FDA Labeling

FDA · Type 2 Diabetes · 6 min

Clinical Trial Cost Analysis 2024: FDA Insights on Phase 1-3 Expenses

FDA · Oncology · 10 min